Loading...
XSHE300765
Market cap8.84bUSD
Dec 24, Last price  
26.80CNY
1D
2.60%
1Q
10.74%
IPO
239.77%
Name

CSPC Innovation Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHE:300765 chart
P/E
85.30
P/S
25.76
EPS
0.31
Div Yield, %
0.15%
Shrs. gr., 5y
9.66%
Rev. gr., 5y
15.07%
Revenues
2.50b
-4.75%
650,715,959742,010,176890,477,1971,031,180,9651,240,098,6911,256,502,3591,317,414,1221,431,987,6642,626,488,8322,501,699,905
Net income
756m
+4.03%
108,235,384115,590,425206,576,912194,911,146223,840,143273,197,126299,835,756393,228,489726,277,891755,557,253
CFO
927m
+44.72%
93,362,300112,048,300137,266,7311,300,210159,727,619315,384,186349,071,664170,592,336640,717,518927,241,226
Dividend
Apr 25, 20240.384 CNY/sh
Earnings
Apr 09, 2025

Profile

CSPC Innovation Pharmaceutical Co., Ltd. manufactures and sells caffeine, and vitamin C health supplement and beverage products. The company is based in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC Pharmaceutical Group Limited.
URL
http://www.xnwpharma.net/
IPO date
Mar 22, 2019
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
2,501,700
-4.75%
2,626,489
83.42%
1,431,988
8.70%
Cost of revenue
1,600,847
1,800,301
1,039,683
Unusual Expense (Income)
NOPBT
900,853
826,188
392,305
NOPBT Margin
36.01%
31.46%
27.40%
Operating Taxes
136,470
124,761
70,554
Tax Rate
15.15%
15.10%
17.98%
NOPAT
764,383
701,427
321,751
Net income
755,557
4.03%
726,278
84.70%
393,228
31.15%
Dividends
(97,848)
(97,562)
(42,000)
Dividend yield
0.23%
1.00%
0.50%
Proceeds from repurchase of equity
483,919
(69)
BB yield
-1.13%
0.00%
Debt
Debt current
223
841
Long-term debt
1,682
19,800
841
Deferred revenue
33,258
37,208
33,727
Other long-term liabilities
1
1
Net debt
(3,420,490)
(2,429,151)
(1,643,776)
Cash flow
Cash from operating activities
927,241
640,718
170,592
CAPEX
(95,732)
Cash from investing activities
(92,986)
311,878
Cash from financing activities
365,206
FCF
819,801
272,266
235,204
Balance
Cash
3,422,173
2,195,684
1,645,457
Long term investments
253,489
Excess cash
3,297,088
2,317,849
1,573,858
Stockholders' equity
4,017,460
2,806,623
2,204,963
Invested Capital
1,824,174
1,644,127
1,403,178
ROIC
44.08%
46.04%
23.63%
ROCE
17.59%
20.85%
13.17%
EV
Common stock shares outstanding
1,170,522
1,114,067
982,800
Price
36.62
317.72%
8.77
2.87%
8.52
6.58%
Market cap
42,864,510
338.89%
9,766,655
16.61%
8,375,641
6.58%
EV
39,452,374
7,346,098
6,740,125
EBITDA
1,000,950
899,132
443,679
EV/EBITDA
39.41
8.17
15.19
Interest
640
219
59
Interest/NOPBT
0.07%
0.03%
0.01%